MDK and neoplasm: In particular, the interaction between Midkine (MDK, secreted by tumor cells) and a number of MDK-receptors (ITGA4, ITGA6, ITGB1, NCL, LRP1) on CD8+ T cells appears to be a recurrent immunosuppressive pathway seen across all three patients (Fig. 6b).